BPC 157 was the only compound that consistently protected against both gastric and duodenal ulcers across all three models, regardless of timing.
Only compound in all 3 modelsBPC 157 was the sole agent providing consistent gastric + duodenal protection across restraint stress, cysteamine, and ethanol models
What the researchers found
BPC 157 was the only tested compound that consistently protected against gastric and duodenal ulcers in all three models, regardless of whether given before, during, or after ulcer induction.
Why it matters
BPC 157's consistent gut protection across multiple models and treatment timings suggests a robust protective mechanism. This study is one of the key early papers establishing BPC-157 as a gastric protective peptide.
How the study worked
Rats received BPC 157 (intraperitoneally or intragastrically) before, during, or after ulcer induction by 48-hour restraint stress, subcutaneous cysteamine, or intragastric 96% ethanol. Results were compared to H2 blockers, dopamine promotors, and gut peptides.
What this study cannot tell us
Animal study in rats. The ulcer models are artificial and may not fully represent human peptic ulcer disease. This study is from the lab that discovered BPC 157, and independent replication is important.
How to read the evidence
Moderate — comprehensive animal study with multiple comparator drugs and models. From the BPC 157 discovering lab; independent replication important.
When this study was published
Published in 1994 (32 years ago). One of the key early BPC 157 gut protection papers.
The bigger picture
BPC 157's consistent gut protection regardless of timing or ulcer type sets it apart from established treatments. Its anti-inflammatory effect adds to its therapeutic potential.
Questions still open
- What is BPC 157's mechanism for such broad gastric protection?
- Could BPC 157 replace or supplement current ulcer medications?
Common questions
How does BPC 157 protect the gut?
Why is it important that it works with any timing?
Read the original research
The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides.
Life sciences, 54(5), PL63-8
Citation
Sikiric, P; Seiwerth, S; Grabarevic, Z; Petek, M; Rucman, R; Turkovic, B; Rotkvic, I; Jagic, V; Duvnjak, M; Mise, S. (1994). The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides.. Life sciences, 54(5), PL63-8.